GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
ARYX THERAPEUTICS I (ARYX) [hlAlert]

Rating:
Buy ARYX
down 99.96 %

ARYX THERAPEUTICS I (ARYX) rated Buy with price target $9 by Jefferies & Co

Posted on: Thursday,  Jul 3, 2008  9:25 AM ET by Jefferies & Co

Jefferies & Co rated Buy ARYX THERAPEUTICS I (OTCBB: ARYX) on 07/03/2008. Previously Jefferies & Co rated Buy ARYX THERAPEUTICS I (OTCBB: ARYX)
on 01/15/2008., when the stock price was $9.24. Since then, ARYX THERAPEUTICS I has lost 99.97% as of 08/27/2015's recent price of $0.00.
If you would have followed the previous Jefferies & Co's recommendation on ARYX, you would have lost 99.96% of your investment in 2781 days.

ARYx Therapeutics is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates designed to eliminate known safety issues associated with well-established, commercially successful drugs. ARYx uses its RetroMetabolic Drug Design(TM) technology to design structurally unique molecules that retain the efficacy of these original drugs but are metabolized through a potentially safer pathway to avoid specific adverse side effects associated with these compounds. ARYx currently has three products in Phase 2 clinical trials: ATI-7505 for the treatment of various gastrointestinal disorders, ATI-5923 for the treatment of patients at risk for the formation of dangerous blood clots, and ATI-2042 for the treatment of atrial fibrillation.

Our focus on growing and mid-sized companies enables us to identify unique investment ideas, which can make the difference in a tough market. Jefferies' research effort covers U.S. & International equity, high yield, convertibles, investment grade fixed income and post-reorganization securities, as well as special situations and quantitative research. The more than 120-person team of research professionals covers over 1,200 companies in more than 40 industries worldwide. Our analysts focus on identifying emerging industry themes and dig deeper to provide in-depth, thought provoking, objective research. Our analysts use a variety of quantitative and qualitative tools, integrating field analysis, proprietary channel checks and ongoing dialogue with the managements of the companies they cover. We utilize the latest technologies to deliver a research product that is timely, differentiated, and tailored to each customer's needs. Regular client access to companies and their management teams is provided through a wide variety of Jefferies hosted industry conferences, company management meetings and on-site tours.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/3/2008 9:25 AM Buy
None
5.35 9.00
as of 12/24/2008
1 Week down  -1.40 %
1 Month up  21.37 %
3 Months up  47.89 %
1 YTD up  21.37 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/15/2008 8:25 AM Buy
None
9.24 17.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy